IA
VTVT icon

IFP Advisors’s vTv Therapeutics VTVT Stock Holding History

IFP Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25
Closed -$2K – 3447
2018
Q4 		$2K Buy
+25
New +$2.31K ﹤0.01% 3201

Other funds holding VTVT

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

IFP Advisors's VTVT Position: Q1 2019 in Review

IFP Advisors sold out of vTv Therapeutics (VTVT) in Q1 2019, closing a stake of 25 shares — an estimated $2K sold.

IFP Advisors first reported a position in VTVT in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 21 funds tracked by Wall St. Rank hold VTVT as of Q1 2019.

  • IFP Advisors reported no remaining vTv Therapeutics position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 25 vTv Therapeutics shares in Q1 2019, an estimated $2K.
  • IFP Advisors first reported a position in vTv Therapeutics in Q4 2018 and held it in 1 quarter.
  • IFP Advisors's vTv Therapeutics position peaked at $2K in Q4 2018.
  • 21 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.